GO FUND IT NOW

NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES

Differentiation of human induced pluripotent stem cells as a tool to study the effects of type 2 diabetes loci.

Differentiation of human induced pluripotent stem cells as a tool to study the effects of type 2 diabetes loci. is a funding opportunity from NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES, up to 4413240.

Funder
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
Funding
4413240
Deadline
Rolling

Overview

A 35-day protocol to reprogram human induced pluripotent stem cells (hiPSCs) into glucose-responsive pancreatic beta-like cells has been developed. Differentiating cells are being used to study the effects of the type 2 diabetes (T2D)-associated variants on beta cell development and insulin secretory function by using…

Differentiation of human induced pluripotent stem cells as a tool to study the effects of type 2 diabetes loci. | Go Fund It Now